Scarica l'app Stockscreener
1.13
4.63%
0.05
Dopo l'orario di chiusura:
1.13
Precedente Chiudi:
$1.08
Aprire:
$1.08
Volume 24 ore:
1.27M
Relative Volume:
0.40
Capitalizzazione di mercato:
$5.32M
Reddito:
-
Utile/perdita netta:
$-4.21M
Rapporto P/E:
-20.62
EPS:
-0.0548
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
-36.16%
6M Prestazione:
-92.07%
1 anno Prestazione:
-99.69%
Intervallo 1D:
$1.07
$1.18
Intervallo di 1 settimana:
$0.98
$1.18
Portata 52W:
$0.98
$392.00
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Nome
Conduit Pharmaceuticals Inc
Settore
Industria
Telefono
(646) 491 9132
Indirizzo
4851 TAMIAMI TRAIL NORTH, NAPLES
Confronta CDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDT
Conduit Pharmaceuticals Inc
|
1.13 | 5.32M | 0 | -4.21M | 0 | -0.0548 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Conduit Pharmaceuticals Inc Borsa (CDT) Ultime notizie
Is Conduit Pharmaceuticals Inc. (CDT) the Best Micro Cap Stock to Buy Now? - Insider Monkey
Conduit Pharmaceuticals Gets Nasdaq Extension, Plans Capital Market Transfer -March 06, 2025 at 10:42 am EST - Marketscreener.com
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - The Manila Times
Conduit Pharmaceuticals secures Nasdaq extension - Investing.com
Conduit Pharmaceuticals Secures Extension for Nasdaq Compliance Following Bid Price Regaining - Nasdaq
Conduit Pharmaceuticals secures Nasdaq extension By Investing.com - Investing.com Australia
Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Down -83.09% So Far This Year: What Will Happen Next? - Stocks Register
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Update - Defense World
Taking a look at what insiders are doing to gauge the Conduit Pharmaceuticals Inc (CDT)’s direction - Knox Daily
Conduit Pharmaceuticals Advances Phase II AI Collaboration With Sarborg To Enhance Drug Development - Nasdaq
Conduit Progresses Phase II of its AI Initiative with Sarborg - The Manila Times
How Conduit's New AI System Could Revolutionize Drug Development Decision-Making - StockTitan
Conduit Pharmaceuticals acts to regain Nasdaq compliance By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals acts to regain Nasdaq compliance - Investing.com India
Conduit Pharmaceuticals Files For Offering Of Up To $17.8 Million Of Shares Of Common StockSEC Filing - Marketscreener.com
Understanding the Risks of Investing in Conduit Pharmaceuticals Inc (CDT) - Knox Daily
Conduit Pharmaceuticals to execute 1-for-100 reverse stock split - MSN
Conduit Pharmaceuticals enacts reverse stock split to meet Nasdaq standards - MSN
Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment - Marketscreener.com
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - The Manila Times
Major Lupus Breakthrough? Conduit Teams Up with Charles River for Game-Changing Treatment Study - StockTitan
Weekly TechBio News 🤹 - substack.com
Conduit Pharmaceuticals announces debt repayment and partial conversion of senior secured note - MSN
Small Cap Stocks To Watch NowFebruary 09th - MarketBeat
Promising Small Cap Stocks To Keep An Eye OnFebruary 07th - MarketBeat
Conduit Pharmaceuticals settles debt, converts senior note - MSN
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - The Manila Times
Conduit Pharmaceuticals settles debt, converts senior note By Investing.com - Investing.com Australia
What is Conduit Pharmaceuticals Inc (CDT) Stock Return on Shareholders’ Capital? - SETE News
Conduit, MGO Global, and Cyclo Therapeutics: Penny Stocks to Watch This Week - PUNE.NEWS
3 Penny Stocks to Watch Now, 2/11/25 - TipRanks
Conduit Pharmaceuticals Inc [CDT] is -58.45% lower this YTD. Is it still time to buy? - The DBT News
CDT’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Biotech Alert: Searches spiking for these stocks today - TipRanks
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Revolutionizing AI Investment: Why Conduit Pharmaceuticals is a Stock to Watch! - Jomfruland.net
Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II - Insider Monkey
Conduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dow Dips 400 Points; US Adds Fewer Than Expected Jobs - Benzinga
CDT Stock Price and Chart — NASDAQ:CDT - TradingView
Stock market news: Conduit Pharmaceuticals +103.87%, Doximity +37.47% among top gainers as corporate earnings surpass investor estimates - Business Upturn
Stock market today: Conduit Pharmaceuticals +83.87%, Doximity +31.02% among top gainers as more companies release their quarterly earnings - Business Upturn
Stock Price Rise As Conduit (CDT) Marks Progress In Strategic Alliance - Stocks Telegraph
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development - The Manila Times
Conduit's AI-Powered Drug Development Takes Major Leap: Real-Time Trial Dashboard Unveiled - StockTitan
Conduit Pharmaceuticals Inc (CDT) requires closer examination - US Post News
Conduit Pharmaceuticals files to sell 5.9M shares of common stock for holders - MSN
Analysts review Conduit Pharmaceuticals Inc’s rating - Knox Daily
Closing Bell Recap: Conduit Pharmaceuticals Inc (CDT) Ends at 1.80, Reflecting a -18.18 Downturn - The Dwinnex
Conduit Pharmaceuticals Inc Azioni (CDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
2.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):